Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 242–243 (2007)Cite this article

Access through your institution
Buy or subscribe

boxed-textSuk Danik J et al. (2006) Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296: 1363–1370

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rifai N et al. (2004) Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin Chem 50: 1364–1371

    Article  CAS  Google Scholar 

  2. Luc G et al. for the PRIME Study Group (2002) Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study. Atherosclerosis 163: 377–384

    Article  CAS  Google Scholar 

  3. Berglund L and Ramakrishnan R (2004) Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 24: 2219–2226

    Article  CAS  Google Scholar 

  4. Kronenberg F et al. (1996) Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 16: 1568–1572

    Article  CAS  Google Scholar 

  5. Shai I et al. (2005) Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur Heart J 26: 1633–1639

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Atherosclerosis, Pasteur Institute of Lille, INSERM U545, 1 Rue du Professeur Calmette, Lille 59019, France jean-charles.fruchart@pasteur-lille.fr

Authors and Affiliations

  1. J-C Fruchart is Professor and Head of the Department of Atherosclerosis at the Pasteur Institute of Lille, INSERM, and University of Lille, Lille, France.,

    Jean-Charles Fruchart

Authors
  1. Jean-Charles Fruchart
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fruchart, JC. Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?. Nat Rev Cardiol 4, 242–243 (2007). https://doi.org/10.1038/ncpcardio0851

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpcardio0851

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing